← brief for 2026-09-16 · Slowing decline

Therapeutic Potential of Pirfenidone in Adenine-Induced Chronic Kidney Disease: An Integrated Experimental and In Silico Study

Paper D Peer reviewed Preclinical

Key takeaways

This study tested pirfenidone, an existing anti-scarring drug used for lung disease, in animals given kidney disease with a chemical called adenine. It also used computer modeling to predict how the drug might work. It was in animals and on computers, not in people yet. No abstract was available, so the results and their size are unknown.

Who did this work

Al Darraji Raad kareem Alwan · Amjad Oraibi · Teeb Ali Al-Saady · Ali Almukram · Safaa Halool Mohammed · Ahmed Hamza AlShammari · Maryam Saleem · Musa A. Said · Musaab Dauelbait · Hafiz Muhammad Zohaib · Omar A. Almohammed

Source

Paper · OpenAlex, CKD works · 2026-09-16
https://doi.org/10.1007/s12010-026-05919-z